0KBS Stock Overview
Recordati Industria Chimica e Farmaceutica S.p.A., junto con sus filiales, se dedica a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos en todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Recordati Industria Chimica e Farmaceutica S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €49.92 |
| 52 Week High | €53.40 |
| 52 Week Low | €39.62 |
| Beta | 0.36 |
| 1 Month Change | -5.53% |
| 3 Month Change | 1.71% |
| 1 Year Change | 25.63% |
| 3 Year Change | 9.57% |
| 5 Year Change | 38.28% |
| Change since IPO | 668.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0KBS | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -2.0% | -0.01% |
| 1Y | 25.6% | -4.9% | 0.8% |
Rentabilidad frente al sector: 0KBS superó al sector UK Pharmaceuticals , que obtuvo un rendimiento del -7.1% el año pasado.
Rentabilidad vs. Mercado: 0KBS superó al mercado UK, que obtuvo un rendimiento del -2.5% el año pasado.
Price Volatility
| 0KBS volatility | |
|---|---|
| 0KBS Average Weekly Movement | 2.4% |
| Pharmaceuticals Industry Average Movement | 8.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Precio estable de las acciones: 0KBS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 0KBS (3%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1926 | 4,455 | Rob Koremans | https://www.recordati.com |
Recordati Industria Chimica e Farmaceutica S.p.A., junto con sus filiales, se dedica a la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos en todo el mundo. La empresa opera a través de los segmentos de Especialidades y Atención Primaria y Enfermedades Raras. Su cartera de productos incluye REC 0559, en fase II, para el tratamiento de la queratitis neurotrófica; REC 0545, para la descompensación aguda en las enfermedades de la orina con jarabe de arce; ISTURISA, para el síndrome de Cushing endógeno; y CYSTADROPS, para los depósitos corneales de cistina en pacientes con cistinosis.
Recordati Industria Chimica e Farmaceutica S.p.A. Fundamentals Summary
| 0KBS fundamental statistics | |
|---|---|
| Market cap | €10.28b |
| Earnings (TTM) | €389.21m |
| Revenue (TTM) | €2.08b |
26.4x
P/E Ratio4.9x
P/S RatioIs 0KBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0KBS income statement (TTM) | |
|---|---|
| Revenue | €2.08b |
| Cost of Revenue | €600.76m |
| Gross Profit | €1.48b |
| Other Expenses | €1.09b |
| Earnings | €389.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 1.89 |
| Gross Margin | 71.15% |
| Net Profit Margin | 18.69% |
| Debt/Equity Ratio | 106.2% |
How did 0KBS perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield63%
Payout RatioDoes 0KBS pay a reliable dividends?
See 0KBS dividend history and benchmarks| Recordati Industria Chimica e Farmaceutica dividend dates | |
|---|---|
| Ex Dividend Date | May 20 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 40 days |
| Days until Dividend pay date | 42 days |
Does 0KBS pay a reliable dividends?
See 0KBS dividend history and benchmarks